Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigational New Drug Application/ Investigational Device Exemption Information

NCT00239226 is registered in ClinicalTrials.gov with Medtronic BRC as lead sponsor.

NCT NCT00239226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00239226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigational New Drug Application/ Investigational Device Exemption Information
Lead sponsor
Medtronic BRC
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2005
Completion date
March 31, 2009
Enrollment
102 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, sinus arrhythmia